Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 470

The DOI matches its Crossref record.

Persistence of Ebola Virus in Ocular Fluid during Convalescence

Open access
Varkey, Jay B., Shantha, Jessica G., Crozier, Ian, Kraft, Colleen S., Lyon, G. Marshall, Mehta, Aneesh K., Kumar, Gokul, Smith, Justine R., Kainulainen, Markus H., Whitmer, Shannon, Ströher, Ute, Uyeki, Timothy M., Ribner, Bruce S., Yeh, Steven·2015·New England Journal of Medicine

Abstract

Summ a r yAmong the survivors of Ebola virus disease (EVD), complications that include uveitis can develop during convalescence, although the incidence and pathogenesis of EVD-associated uveitis are unknown.We describe a patient who recovered from EVD and was subsequently found to have severe unilateral uveitis during convalescence.Viable Zaire ebolavirus (EBOV) was detected in aqueous humor 14 weeks after the onset of EVD and 9 weeks after the clearance of viremia.T he current outbreak of EVD is believed to have begun in December 2013. 1 As of April 26, 2015, a total of 26,312 cases of EVD (including 10,899 deaths) had been reported in six countries in West Africa (i.e., Sierra Leone, Liberia, Guinea, Mali, Nigeria, and Senegal), the United States, the United Kingdom, and Spain. 2 The outbreak has also resulted in the largest number of EVD survivors in history.Among survivors of EVD, late complications that include ocular disease can develop during convalescence.3,4 However, few systematic studies have been conducted on post-EVD sequelae, so the incidence and clinical manifestations of post-EVD ocular complications are unclear.Here, we report the clinical course of a man in whom severe, acute, unilateral uveitis developed during the convalescent phase of EVD.We also report the detection of viable EBOV in aqueous humor obtained from the inflamed eye 14 weeks after the onset of the initial symptoms of EVD and 9 weeks after the clearance of viremia. C a se R eportA previously healthy 43-year-old male physician received a diagnosis of EVD on September 6, 2014, while he was working in an Ebola treatment unit in Kenema, Sierra Leone.He was transferred to Emory University Hospital in Atlanta and arrived 4 days after the onset of symptoms.He was treated with an experimental small interfering RNA antiviral agent (TKM-100802, Tekmira Pharmaceuticals), convalescent plasma, and aggressive supportive care.5 The hospital course was complicated by multiorgan system failure requiring mechanical ventilation for 12 days and hemodialysis for 24 days.6 After extubation, the patient had altered mental status, difficulty walking related to severe proximal From the Department of Medicine, Division of Infectious Diseases (J.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1500306

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 470

Metadata

Authors
Varkey, J. B., Shantha, J. G., Crozier, I., Kraft, C. S., Lyon, G. M., Mehta, A. K., Kumar, G., Smith, J. R., Kainulainen, M. H., Whitmer, S., Ströher, U., Uyeki, T. M., Ribner, B. S., & Yeh, S.
Venue
New England Journal of Medicine
Published
2015-06-18
Volume
372
Issue
25
Pages
2423-2427
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W277041599
Cited by
470
References
0
FWCI
59.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Persistence of Ebola Virus in Ocular Fluid during Convalescence. https://app.cochat.ai/papers/10.1056/nejmoa1500306
The paper
Varkey, J. B., Shantha, J. G., Crozier, I., Kraft, C. S., Lyon, G. M., Mehta, A. K., Kumar, G., Smith, J. R., Kainulainen, M. H., Whitmer, S., Ströher, U., Uyeki, T. M., Ribner, B. S., & Yeh, S. (2015). Persistence of Ebola Virus in Ocular Fluid during Convalescence. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1500306

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.